{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:31:13Z","timestamp":1787776273898,"version":"build-2784847793"},"reference-count":77,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Carlos III Health Institute (ISCIII)","award":["PI20\/00923"],"award-info":[{"award-number":["PI20\/00923"]}]},{"name":"Carlos III Health Institute (ISCIII)","award":["PI24\/00978"],"award-info":[{"award-number":["PI24\/00978"]}]},{"name":"Carlos III Health Institute (ISCIII)","award":["RTC2019-006826-1"],"award-info":[{"award-number":["RTC2019-006826-1"]}]},{"DOI":"10.13039\/501100004837","name":"Spain\u2019s Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["PI20\/00923"],"award-info":[{"award-number":["PI20\/00923"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Spain\u2019s Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["PI24\/00978"],"award-info":[{"award-number":["PI24\/00978"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Spain\u2019s Ministry of Science and Innovation","doi-asserted-by":"publisher","award":["RTC2019-006826-1"],"award-info":[{"award-number":["RTC2019-006826-1"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish Society of Cardiology","award":["PI20\/00923"],"award-info":[{"award-number":["PI20\/00923"]}]},{"name":"Spanish Society of Cardiology","award":["PI24\/00978"],"award-info":[{"award-number":["PI24\/00978"]}]},{"name":"Spanish Society of Cardiology","award":["RTC2019-006826-1"],"award-info":[{"award-number":["RTC2019-006826-1"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Natriuretic peptides are established biomarkers related to the prognosis of heart failure. New biomarkers have emerged in the field of cardiovascular disease. The prognostic value of these biomarkers in heart failure with reduced left ventricular ejection fraction is not well-established. We conducted a prospective, single-centre study, including (July 2019 to March 2023) 104 patients being consecutively admitted with a diagnosis of acute heart failure with reduced ejection fraction decompensation. The median follow-up was 23.5 months, during which 20 deaths (19.4%) and 21 readmissions for heart failure (20.2%) were recorded. Plasma biomarkers, such as NT-proBNP, GDF-15, sST2, suPAR, and FGF-23, were associated with an increased risk of all-cause mortality. However, a Cox regression analysis showed that the strongest predictors of mortality were an estimated glomerular filtration rate (HR 0.96 [0.93\u20130.98]), GDF-15 (HR 1.3 [1.16\u20131.45]), and sST2 (HR 1.2 [1.11\u20131.35]). The strongest predictive model was formed by the combination of the glomerular filtration rate and sST2 (C-index 0.758). In conclusion, in patients with acute decompensated heart failure with reduced ejection fraction, GDF-15 and sST2 showed the highest predictive power for all-cause mortality, which was superior to other established biomarkers such as natriuretic peptides. GDF-15 and sST2 may provide additional prognostic information to improve the prognostic assessment.<\/jats:p>","DOI":"10.3390\/ijms26030986","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T05:24:31Z","timestamp":1737696271000},"page":"986","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["New Biomarkers in the Prognostic Assessment of Acute Heart Failure with Reduced Ejection Fraction: Beyond Natriuretic Peptides"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2304-8547","authenticated-orcid":false,"given":"Marcelino","family":"Cort\u00e9s","sequence":"first","affiliation":[{"name":"Cardiology Department, Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, 28040 Madrid, Spain"},{"name":"Faculty of Medicine and Biomedicine, Universidad Alfonso X el Sabio (UAX), 28691 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3458-0328","authenticated-orcid":false,"given":"Jairo","family":"Lumpuy-Castillo","sequence":"additional","affiliation":[{"name":"Laboratory of Diabetes and Vascular Pathology, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma, 28040 Madrid, Spain"},{"name":"Biomedical Research Network on Diabetes and Associated Metabolic Disorders (CIBERDEM), Carlos III National Health Institute, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Sof\u00eda","family":"Garc\u00eda-Talavera","sequence":"additional","affiliation":[{"name":"Cardiology Department, Complejo Hospitalario San Mill\u00e1n\u2014San Pedro, 26004 Logrono, La Rioja, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Bel\u00e9n","family":"Arroyo Rivera","sequence":"additional","affiliation":[{"name":"Cardiology Department, HM Montepr\u00edncipe University Hospital, 28660 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5006-6257","authenticated-orcid":false,"given":"Lara","family":"de Miguel","sequence":"additional","affiliation":[{"name":"Cardiology Department, Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4612-3949","authenticated-orcid":false,"given":"Antonio Jos\u00e9","family":"Bollas","sequence":"additional","affiliation":[{"name":"Cardiology Department, Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Maria","family":"Romero-Otero","sequence":"additional","affiliation":[{"name":"Cardiology Department, Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Antonio","family":"Esteban Chapel","sequence":"additional","affiliation":[{"name":"Cardiology Department, Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2404-3657","authenticated-orcid":false,"given":"Mikel","family":"Taibo-Urqu\u00eda","sequence":"additional","affiliation":[{"name":"Cardiology Department, Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, 28040 Madrid, Spain"},{"name":"Faculty of Medicine and Biomedicine, Universidad Alfonso X el Sabio (UAX), 28691 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Pello","sequence":"additional","affiliation":[{"name":"Cardiology Department, Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, 28040 Madrid, Spain"},{"name":"Faculty of Medicine and Biomedicine, Universidad Alfonso X el Sabio (UAX), 28691 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1268-7191","authenticated-orcid":false,"given":"Mar\u00eda Luisa","family":"Gonz\u00e1lez-Casaus","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, La Paz University Hospital, 28046 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0558-6541","authenticated-orcid":false,"given":"Ignacio","family":"Mah\u00edllo-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Biostatistics and Epidemiology Unit, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz, 28040 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5515-6078","authenticated-orcid":false,"given":"Oscar","family":"Lorenzo","sequence":"additional","affiliation":[{"name":"Laboratory of Diabetes and Vascular Pathology, IIS-Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma, 28040 Madrid, Spain"},{"name":"Biomedical Research Network on Diabetes and Associated Metabolic Disorders (CIBERDEM), Carlos III National Health Institute, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1373-0999","authenticated-orcid":false,"given":"Jos\u00e9","family":"Tu\u00f1\u00f3n","sequence":"additional","affiliation":[{"name":"Cardiology Department, Fundaci\u00f3n Jim\u00e9nez D\u00edaz University Hospital, 28040 Madrid, Spain"},{"name":"Department of Medicine, Faculty of Medicine, Universidad Aut\u00f3noma de Madrid, 28049 Madrid, Spain"},{"name":"Biomedical Research Network on Cardiovascular Diseases CIBERCV, Carlos III National Health Institute, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ejhf.110","article-title":"Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion","volume":"16","author":"Hoes","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","article-title":"Clinical epidemiology of heart failure","volume":"93","author":"Mosterd","year":"2007","journal-title":"Heart"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jchf.2014.04.008","article-title":"Risk prediction in patients with heart failure: A systematic review and analysis","volume":"2","author":"Rahimi","year":"2014","journal-title":"JACC Heart Fail."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jchf.2014.04.006","article-title":"Factors influencing the predictive power of models for predicting mortality and\/or heart failure hospitalization in patients with heart failure","volume":"2","author":"Ouwerkerk","year":"2014","journal-title":"JACC Heart Fail."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e1054","DOI":"10.1161\/CIR.0000000000000490","article-title":"Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement from the American Heart Association","volume":"135","author":"Chow","year":"2017","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/ejhf.2346","article-title":"Circulating heart failure biomarkers beyond natriuretic peptides: Review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)","volume":"23","author":"Meijers","year":"2021","journal-title":"Eur. J. Heart Fail."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2022.08.009","article-title":"Heart Failure Drug Treatment\u2014Inertia, Titration, and Discontinuation","volume":"11","author":"Savarese","year":"2023","journal-title":"JACC Heart Fail."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart Disease and Stroke Statistics-2022 Update: A Report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/ejhf.813","article-title":"Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: An analysis of the ESC Heart Failure Long-Term Registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/CRD.0000000000000224","article-title":"Evolving Use of Biomarkers in the Management of Heart Failure","volume":"27","author":"Paul","year":"2019","journal-title":"Cardiol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"h910","DOI":"10.1136\/bmj.h910","article-title":"The diagnostic accuracy of the natriuretic peptides in heart failure: Systematic review and diagnostic meta-analysis in the acute care setting","volume":"350","author":"Roberts","year":"2015","journal-title":"BMJ"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ejhf.1494","article-title":"Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations","volume":"21","author":"Mueller","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1373\/clinchem.2003.024760","article-title":"Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: A review","volume":"50","author":"Clerico","year":"2004","journal-title":"Clin. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijcard.2014.08.007","article-title":"Obesity and natriuretic peptides, BNP and NT-proBNP: Mechanisms and diagnostic implications for heart failure","volume":"176","author":"Madamanchi","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0002-8703(98)70041-9","article-title":"Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction","volume":"135","author":"Maeda","year":"1998","journal-title":"Am. Heart J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","article-title":"Reappraising the role of inflammation in heart failure","volume":"17","author":"Adamo","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in Heart Failure: JACC State-of-the-Art Review","volume":"75","author":"Murphy","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","article-title":"MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily","volume":"94","author":"Bootcov","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/geno.1999.5767","article-title":"Interleukin-1 Receptor Cluster: Gene Organization ofIL1R2, IL1R1, IL1RL2(IL-1Rrp2), IL1RL1(T1\/ST2), and IL18R1(IL-1Rrp) on Human Chromosome 2q","volume":"57","author":"Dale","year":"1999","journal-title":"Genomics"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.tem.2020.10.004","article-title":"Insights Into Mechanisms of GDF15 and Receptor GFRAL: Therapeutic Targets","volume":"31","author":"Rochette","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11897-023-00610-4","article-title":"Growth Differentiation Factor 15 (GDF-15), a New Biomarker in Heart Failure Management","volume":"20","author":"Sawalha","year":"2023","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/eurjhf\/hfr047","article-title":"Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: Complementary role for risk stratification in acutely decompensated heart failure","volume":"13","author":"Boronat","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Katsioupa, M., Kourampi, I., Oikonomou, E., Tsigkou, V., Theofilis, P., Charalambous, G., Marinos, G., Gialamas, I., Zisimos, K., and Anastasiou, A. (2023). Novel Biomarkers and Their Role in the Diagnosis and Prognosis of Acute Coronary Syndrome. Life, 13.","DOI":"10.3390\/life13101992"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1373\/clinchem.2016.255174","article-title":"Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease","volume":"63","author":"Wollert","year":"2017","journal-title":"Clin. Chem."},{"key":"ref_26","first-page":"203","article-title":"Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: Observations from PROVE IT-TIMI 22","volume":"31","author":"Bonaca","year":"2011","journal-title":"Arter. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12933-020-01092-7","article-title":"Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease","volume":"19","author":"Li","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ijcard.2017.03.101","article-title":"Circulating GDF-15 levels predict future secondary manifestations of cardiovascular disease explicitly in women but not men with atherosclerosis","volume":"241","author":"Gohar","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ahj.2013.09.013","article-title":"Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study)","volume":"167","author":"Schopfer","year":"2014","journal-title":"Am. Heart J."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"C\u0103lburean, P.-A., Lupu, S., Hu\u021banu, A., Oprica, M., Opri\u0219, D.R., Stan, A., Scurtu, A.-C., Ani\u021bei, D., Harpa, M., and Br\u00eenzaniuc, K. (2024). Natriuretic peptides and soluble ST2 improves echocardiographic diagnosis of elevated left ventricular filling pressures. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-73349-0"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/eurjhf\/hfq151","article-title":"The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction","volume":"12","author":"Stahrenberg","year":"2010","journal-title":"Eur. J. Heart Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/ehf2.12757","article-title":"Circulating protein biomarkers predict incident hypertensive heart failure independently of N-terminal pro-B-type natriuretic peptide levels","volume":"7","author":"Fernandez","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/ehf2.12680","article-title":"Multimarker approach including CRP, sST2 and GDF-15 for prognostic stratification in stable heart failure","volume":"7","author":"Kuster","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cjca.2018.12.027","article-title":"The Role of GDF-15 in Heart Failure Patients with Chronic Kidney Disease","volume":"35","author":"Benes","year":"2019","journal-title":"Can. J. Cardiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/ejhf.1301","article-title":"Growth differentiation factor-15 is not modified by sacubitril\/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: The PARADIGM-HF trial","volume":"20","author":"Bouabdallaoui","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1111\/jcmm.13540","article-title":"GDF-15 is a better complimentary marker for risk stratification of arrhythmic death in non-ischaemic, dilated cardiomyopathy than soluble ST2","volume":"22","author":"Stojkovic","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.CIR.0000047274.66749.FE","article-title":"Identification of serum soluble ST2 receptor as a novel heart failure biomarker","volume":"107","author":"Weinberg","year":"2003","journal-title":"Circulation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCHEARTFAILURE.110.958223","article-title":"High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure","volume":"4","author":"Ky","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mayocp.2012.09.016","article-title":"Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment","volume":"88","author":"Vila","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.jacc.2018.08.2165","article-title":"sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T\u2032","volume":"72","author":"Emdin","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000509660","article-title":"Long-Term and Short-Term Prognostic Value of Circulating Soluble Suppression of Tumorigenicity-2 Concentration in Chronic Heart Failure: A Systematic Review and Meta-Analysis","volume":"146","author":"Dong","year":"2021","journal-title":"Cardiology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1016\/j.ijcard.2013.12.101","article-title":"Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction","volume":"172","author":"Gruson","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jchf.2016.12.016","article-title":"Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure","volume":"5","author":"Aimo","year":"2017","journal-title":"JACC Heart Fail."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1536\/ihj.16-219","article-title":"Predictors of Long-Term Mortality in Patients with Acute Heart Failure","volume":"58","author":"Jin","year":"2017","journal-title":"Int. Heart J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"100887","DOI":"10.1016\/j.ijcha.2021.100887","article-title":"Soluble suppression of tumorigenicity 2 (sST2) for predicting disease severity or mortality outcomes in cardiovascular diseases: A systematic review and meta-analysis","volume":"37","author":"Ip","year":"2021","journal-title":"IJC Heart Vasc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.jacc.2017.09.026","article-title":"Prognostic Value of Serial ST2 Measurements in Patients with Acute Heart Failure","volume":"70","author":"Baart","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/ehf2.13377","article-title":"Dynamics of growth differentiation factor 15 in acute heart failure","volume":"8","author":"Cunha","year":"2021","journal-title":"ESC Heart Fail."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"\u00c1lvarez-Garc\u00eda, J., Garc\u00eda-Osuna, \u00c1., Vives-Borr\u00e1s, M., Ferrero-Gregori, A., Mart\u00ednez-Sell\u00e9s, M., V\u00e1zquez, R., Gonz\u00e1lez-Juanatey, J.R., Rivera, M., Segovia, J., and Pascual-Figal, D. (2021). A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.708890"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1097\/CM9.0000000000000449","article-title":"Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction value for patients with acute heart failure: A prospective cohort study","volume":"132","author":"Hao","year":"2019","journal-title":"Chin. Med. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.amjcard.2010.09.011","article-title":"Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction","volume":"107","author":"Mueller","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jacc.2020.09.617","article-title":"Vitamin D, Calcium Supplements, and Implications for Cardiovascular Health","volume":"77","author":"Michos","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jash.2017.04.001","article-title":"Fibroblast growth factor-23 is independently associated with cardiac mass in African-American adolescent males","volume":"11","author":"Falkner","year":"2017","journal-title":"J. Am. Soc. Hypertens."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/jamacardio.2018.0139","article-title":"Association of Fibroblast Growth Factor 23 with Risk of Incident Coronary Heart Disease in Community-Living Adults","volume":"3","author":"Panwar","year":"2018","journal-title":"JAMA Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Liu, M., Xia, P., Tan, Z., Song, T., Mei, K., Wang, J., Ma, J., Jiang, Y., Zhang, J., and Zhao, Y. (2022). Fibroblast growth factor-23 and the risk of cardiovascular diseases and mortality in the general population: A systematic review and dose-response meta-analysis. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.989574"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00774-015-0706-y","article-title":"Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate","volume":"34","author":"Lorenzo","year":"2016","journal-title":"J. Bone Miner Metab."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Tunon, J., Crist\u00f3bal, C., Vicente, M.N.T., Ace\u00f1a, \u00c1., Gonzalez-Casaus, M.L., Huelmos, A., Alonso, J.J., Lorenzo, \u00d3., Gonz\u00e1lez-Parra, E., and Mah\u00edllo-Fern\u00e1ndez, I. (2014). Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095402"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e001278","DOI":"10.1161\/JAHA.114.001278","article-title":"Serum Parathyroid Hormone and 25-Hydroxyvitamin D Concentrations and Risk of Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis","volume":"3","author":"Bansal","year":"2014","journal-title":"J. Am. Hear. Assoc."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/eurjhf\/hfq106","article-title":"Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community","volume":"12","author":"Dhingra","year":"2010","journal-title":"Eur. J. Hear. Fail."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e024952","DOI":"10.1161\/JAHA.121.024952","article-title":"Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure with Preserved or Reduced Ejection Fraction: The PREVEND Study","volume":"11","author":"Binnenmars","year":"2022","journal-title":"J. Am. Hear. Assoc."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/ejhf.2543","article-title":"Multi-variable biomarker approach in identifying incident heart failure in chronic kidney disease: Results from the Chronic Renal Insufficiency Cohort study","volume":"24","author":"Janus","year":"2022","journal-title":"Eur. J. Hear. Fail."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Xu, J.-P., Zeng, R.-X., He, M.-H., Lin, S.-S., Guo, L.-H., and Zhang, M.-Z. (2022). Associations Between Serum Soluble \u03b1-Klotho and the Prevalence of Specific Cardiovascular Disease. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.899307"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijcard.2022.11.010","article-title":"Association between serum Klotho concentration and heart failure in adults, a cross-sectional study from NHANES 2007\u20132016","volume":"370","author":"Cai","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"ref_63","first-page":"1","article-title":"Association between serum \u03b1-klotho level and the prevalence of heart failure in the general population","volume":"34","author":"Luo","year":"2023","journal-title":"Cardiovasc. J. Afr."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1002\/ehf2.13331","article-title":"Parathormone levels add prognostic ability to N-terminal pro-brain natriuretic peptide in stable coronary patients","volume":"8","author":"Pello","year":"2021","journal-title":"ESC Hear. Fail."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/ehf2.14568","article-title":"Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome","volume":"11","author":"Kallmeyer","year":"2024","journal-title":"ESC Hear. Fail."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ejhf.49","article-title":"Increased plasma level of soluble urokinase plasminogen activator receptor is associated with incidence of heart failure but not atrial fibrillation","volume":"16","author":"Persson","year":"2014","journal-title":"Eur. J. Hear. Fail."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1475-2840-12-72","article-title":"Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients","volume":"12","author":"Valdovinos","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.peptides.2012.08.003","article-title":"C-terminal FGF23 is a strong predictor of survival in systolic heart failure","volume":"37","author":"Gruson","year":"2012","journal-title":"Peptides"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/CIRCHEARTFAILURE.115.002341","article-title":"Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients with Heart Failure and Reduced Ejection Fraction","volume":"8","author":"Koller","year":"2015","journal-title":"Circ. Hear. Fail."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jchf.2015.05.012","article-title":"Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure","volume":"3","author":"Wohlfahrt","year":"2015","journal-title":"JACC Hear. Fail."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1515\/cclm-2020-0903","article-title":"Long term pronostic value of suPAR in chronic heart failure: Reclassification of patients with low MAGGIC score","volume":"59","author":"Dupuy","year":"2021","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cardfail.2022.08.010","article-title":"Soluble Urokinase Plasminogen Activator Receptor Levels and Outcomes in Patients with Heart Failure","volume":"29","author":"Hayek","year":"2022","journal-title":"J. Card. Fail."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Calvo, R., Granado-Casas, M., de Oca, A.P.-M., Julian, M.T., Domingo, M., Codina, P., Santiago-Vacas, E., Cediel, G., Julve, J., and Rossell, J. (2023). Fatty Acid Binding Proteins 3 and 4 Predict Both All-Cause and Cardiovascular Mortality in Subjects with Chronic Heart Failure and Type 2 Diabetes Mellitus. Antioxidants, 12.","DOI":"10.3390\/antiox12030645"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jchf.2016.12.008","article-title":"Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients with Chronic Heart Failure","volume":"5","author":"Koller","year":"2017","journal-title":"JACC Hear. Fail."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Cornelissen, A., Florescu, R., Kneizeh, K., Cornelissen, C., Brandenburg, V., Liehn, E., and Schuh, A. (2021). Intact fibroblast growth factor 23 levels and outcome prediction in patients with acute heart failure. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-94780-7"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1002\/ehf2.14071","article-title":"Biomarker prognostication across Universal Definition of Heart Failure stages","volume":"9","author":"Mohebi","year":"2022","journal-title":"ESC Hear. Fail."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/3\/986\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:35:20Z","timestamp":1759919720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/3\/986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":77,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["ijms26030986"],"URL":"https:\/\/doi.org\/10.3390\/ijms26030986","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]}}}